UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE 
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 21, 2019 (June 21, 2019)

 

Global Medical REIT Inc.
(Exact name of registrant as specified in its charter)

  

Maryland 001-37815 46-4757266
(State or Other Jurisdiction 
of Incorporation)
(Commission 
File Number)
(I.R.S. Employer 
Identification No.)

 

2 Bethesda Metro Center, Suite 440

Bethesda, MD

20814

(Address of Principal Executive Offices) 

(Zip Code)

 

(202) 524-6851

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol:   Name of each exchange on which registered:
Common Stock, par value $0.001 per share   GMRE   NYSE
         
Series A Preferred Stock, par value $0.001 per share   GMRE PrA   NYSE

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On June 21, 2019, Global Medical REIT Inc. (the “Company”) entered into an amendment (the “Amendment”) of the Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) by and among the Company, Inter-American Management, LLC, the Company’s external advisor, and Global Medical REIT L.P., the Company’s operating partnership, on the one hand, and Cantor Fitzgerald & Co., B. Riley FBR, Inc., BMO Capital Markets Corp., D.A. Davidson & Co., H.C. Wainwright & Co., LLC, The Huntington Investment Company and Robert W. Baird & Co. Incorporated, on the other hand. The Amendment modifies the Agreement to include Stifel, Nicolaus & Company, Incorporated as an additional sales agent.

 

The foregoing description of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amendment, which is attached as Exhibit 1.1 hereto and is incorporated by reference herein.

 

Item 9.01 Financial Statement and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
1.1   Amendment No. 1 to the Controlled Equity Offering SM Sales Agreement, dated June 21, 2019, by and among the Company, Global Medical REIT L.P. and Inter-American Management, LLC, on the one hand, and Cantor Fitzgerald & Co., B. Riley FBR, Inc., BMO Capital Markets Corp., D.A. Davidson & Co., H.C. Wainwright & Co., LLC, The Huntington Investment Company, Robert W. Baird & Co. Incorporated and Stifel, Nicolaus & Company, Incorporated, on the other hand

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Global Medical REIT Inc.
       
  By:   /s/ Jamie A. Barber
      Jamie A. Barber
      Secretary and General Counsel

 

Dated: June 21, 2019

 

 

 

 

Exhibit 1.1

 

GLOBAL MEDICAL REIT INC.

 

AMENDMENT NO. 1 TO

 

CONTROLLED EQUITY OFFERING SM SALES AGREEMENT

 

June 21, 2019

 

CANTOR FITZGERALD & CO.
499 Park Avenue
New York, NY 10022

 

H.C. Wainwright & Co., LLC

430 Park Avenue

New York, NY 10022

B. RILEY FBR, INC.

299 Park Avenue, 7th Floor

New York, NY 10171

The Huntington Investment Company

41 S. High Street

HC0520

Columbus, OH 43287

 

BMO CAPITAL MARKETS CORP.

3 Times Square, 25th Floor

New York, NY 10036

 

Robert W. Baird & Co. Incorporated

777 E. Wisconsin Avenue

Milwaukee, WI 53202

D.A. Davidson & Co.

8 Third Street North

Great Falls, MT 59401

Stifel, Nicolaus & Company, Incorporated

501 North Broadway, 10th Floor

Saint Louis, MO 63102

 

Ladies and Gentlemen:

 

Reference is made to the Controlled Equity Offering SM Sales Agreement, dated as of August 17, 2018 (the “ Agreement ”), by and among Global Medical REIT Inc., a Maryland corporation (the “ Company ”), Global Medical REIT L.P., a Delaware limited partnership and the Company’s operating partnership (the “ Operating Partnership ”), and Inter-American Management, LLC, a Delaware limited liability company and the manager of the Company (the “ Manager ”), on the one hand, and Cantor Fitzgerald & Co., B. Riley FBR, Inc., BMO Capital Markets Corp., D.A. Davidson & Co., H.C. Wainwright & Co., LLC, The Huntington Investment Company and Robert W. Baird & Co. Incorporated (each an “ Existing Agent ” and collectively, the “ Existing Agents ” and together with the Company, the Operating Partnership and the Manager, the “ Parties ”) pursuant to which the Company may issue and sell through the Existing Agents, each acting as agent and/or principal, shares of the Company’s common stock, par value $0.001 per share, having an aggregate sale price of up to $50,000,000. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Agreement.

 

In connection with the foregoing, the Parties wish to amend the Agreement through this Amendment No. 1 to the Controlled Equity Offering SM Sales Agreement (this “ Amendment ”) to modify the definition of certain defined terms set forth in the Agreement and used therein and to make certain other changes to the Agreement with effect on and after the date hereof (the “ Effective Date ”).

 

 

 

 

SECTION 1. Amendments to the Agreement . The Parties agree, from and after the Effective Date, that:

 

a.   The definitions of the terms “ Agent ” and “ Agents ” are hereby amended to read as follows: “Cantor Fitzgerald & Co., B. Riley FBR, Inc., BMO Capital Markets Corp., D.A. Davidson & Co., H.C. Wainwright & Co., LLC, The Huntington Investment Company, Robert W. Baird & Co. Incorporated and Stifel, Nicolaus & Company, Incorporated (each an “ Agent ” and collectively, the “ Agents ”).”

 

b.   Section 12 of the Agreement is hereby amended to include the following immediately after the contact information for Robert W. Baird & Co. Incorporated:

 

“Stifel, Nicolaus & Company, Incorporated

One South Street, 15th Floor

Baltimore, MD 21202

  Attention: Syndicate Department
  Facsimile: 443-224-1273”

 

c.   Schedule 2 to the Agreement shall be replaced in its entirety with the version attached hereto.

 

SECTION 2. Obligations Binding upon Stifel, Nicolaus & Company, Incorporated. Stifel, Nicolaus & Company, Incorporated hereby agrees to be bound by the terms of the Agreement. Stifel, Nicolaus & Company, Incorporated shall be considered to be an Agent under the Agreement to the same extent as if it were a party to the Agreement on the date of the execution thereof.

 

SECTION 3. No Other Amendments; References to Agreements . Except as set forth in this Amendment, all other terms and provisions of the Agreement shall continue in full force and effect. All references to the Agreement in the Agreement or in any other document executed or delivered in connection therewith shall, from the date hereof, be deemed a reference to the Agreement as amended by this Amendment.

 

SECTION 4. GOVERNING LAW AND TIME; WAIVER OF JURY TRIAL . THIS AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

2  

 

 

SECTION 5. CONSENT TO JURISDICTION . EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AMENDMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.

 

SECTION 6. Counterparts . This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Amendment by one party to the other may be made by facsimile or electronic transmission.

 

SECTION 7. Construction . The section and exhibit headings herein are for convenience only and shall not affect the construction hereof. References herein to any law, statute, ordinance, code, regulation, rule or other requirement of any Governmental Authority shall be deemed to refer to such law, statute, ordinance, code, regulation, rule or other requirement of any Governmental Authority as amended, reenacted, supplemented or superseded in whole or in part and in effect from time to time and also to all rules and regulations promulgated thereunder.

 

[Signature Page Follows]

 

3  

 

 

If the foregoing correctly sets forth the understanding among the Company, the Operating Partnership, the Manager and each Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement among the Company, the Operating Partnership, the Manager and each of the Agents.

 

  Very truly yours,
     
  GLOBAL MEDICAL REIT INC.
     
  By: /s/ Jeff Busch
  Name: Jeff Busch
  Title: Chief Executive Officer and President

 

 

  GLOBAL MEDICAL REIT L.P.
   
  By: Global Medical REIT GP LLC
  Its: General Partner
   
  By: Global Medical REIT Inc.
  Its: Sole Member

 

 

  By: /s/ Jeff Busch
  Name: Jeff Busch
  Title: Chief Executive Officer and President
     
  INTER-AMERICAN MANAGEMENT, LLC
     
     
  By: /s/ Jeff Busch
  Name: Jeff Busch
  Title: President

 

SIGNATURE PAGE

GLOBAL MEDICAL REIT INC. – Amendment No. 1 to Sales Agreement

 

 

 

 

ACCEPTED as of the date first-above written:

 

CANTOR FITZGERALD & CO.   H.C. WAINWRIGHT & CO., LLC
     
         
By: /s/ Mark Kaplan   By: /s/ Edward D. Silvera
Name: Mark Kaplan   Name: Edward D. Silvera
Title: Global CEO   Title: Chief Operating Officer
         
B. RILEY FBR, INC.   The Huntington Investment Company
     
         
By: /s/ Patrice McNicoll      
Name: Patrice McNicoll   By: /s/ Peter Dippolito
Title: Co-Head, Investment Banking   Name: Peter Dippolito
      Title: Senior Manager
         
BMO CAPITAL MARKETS CORP.      
      ROBERT W. BAIRD & CO. INCORPORATED
By: /s/ David Raff      
Name: David Raff      
Title: Managing Director   By: /s/ B. William Bartlett
      Name: B. William Bartlett
D.A. DAVIDSON & CO.   Title: Vice President
         
      Stifel, Nicolaus & Company, Incorporated
By: /s/ Keith E. Getter      
Name: Keith E. Getter      
Title: Managing Director      
      By: /s/ Chad M. Gorsuch
      Name: Chad M. Gorsuch
      Title: Managing Director

 

SIGNATURE PAGE

GLOBAL MEDICAL REIT INC. – Amendment No. 1 to Sales Agreement

 

 

 

 

SCHEDULE 2

 

NOTICE PARTIES

 

The Company

 

Jeffrey Busch (jeffb@interamc.com)

Robert J. Kiernan (bobk@interamc.com)

Jamie A. Barber (jamieb@globalmedicalreit.com)

 

The Agents

 

Cantor Fitzgerald & Co.

Sameer Vasudev (svasudev@cantor.com)

with copies to:

CFCEO@cantor.com

 

B. Riley FBR, Inc.

Larry Goldsmith Jr. (lgoldsmith@brileyfbr.com)

Patrice McNicoll (pmcnicoll@brileyfbr.com)

Ryan Loforte (rloforte@brileyfbr.com)

Keith Pompliano (kpompliano@brileyfbr.com)

Scott Ammaturo (sammaturo@brileyfbr.com)

with copies to:

atmdesk@brileyfbr.com

atmadmin@brileyfbr.com

 

BMO Capital Markets Corp.

Dave Raff (David.Raff@bmo.com)

Eric Benedict (Eric.Benedict@bmo.com)

Jaryd Banach (jaryd.banach@bmo.com)

Alex Watson (Alexander.watson@bmo.com)

 

 

 

 

D.A. Davidson & Co.

atmofferingdadavidson@dadco.com

 

H.C. Wainwright & Co., LLC

ATM@hcwco.com

 

The Huntington Investment Company

Peter Dippolito (peter.dippolito@huntington.com)

Barry Fredrickson (barry.fredrickson@huntington.com)

Jon Novak (jon.novak@huntington.com)

Jay Clutter (jay.clutter@huntington.com)

with copies to:

ATMOfferings@huntington.com

 

Robert W. Baird & Co. Incorporated

John Roesner (jroesner@rwbaird.com)

Barbara Nelson (banelson@rwbaird.com)

 

Stifel, Nicolaus & Company, Incorporated

Chad Gorsuch (cmgorsuch@stifel.com)

Steve Zimmerman (zimmermans@stifel.com)

Dan Covatta (dcovatta@stifel.com)

Mark White (whitem@stifel.com)

 

SIGNATURE PAGE

GLOBAL MEDICAL REIT INC. – Amendment No. 1 to Sales Agreement